Improving Outcomes in Heart Failure – Focus on Guideline Adherence and Comorbidities

Published: 29 September 2020

  • Views:

    Views Icon 265

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

In this series from the e-SPACE Heart Failure Global Web-Conference, Ileana Piña, Peter van der Meer and Stefan Anker discuss improving outcomes in heart failure with a focus on guideline adherence and comorbidities.

Organised by MedEd Global Solutions and supported by an unrestricted grant from Vifor Pharma

Educational objectives

  • Review Pharmacological Treatments That Reduce Mortality and Hospitalisations in Patients With Heart Failure
  • Evaluate Adherence to Heart Failure Management Guidelines and Barriers to Optimal Use of Guideline-Recommended Therapy
  • Recognise the Importance of Integrated Care of Comorbidities in the Management of Heart Failure Patients
  • Assess the Role of Novel Potassium Binders in Optimising Optimal Renin–Angiotensin– Aldosterone System Inhibitor (RAASi) Therapy in Patients With Heart Failure
  • Review the Benefits of Treating Iron Deficiency in Heart Failure With Respect to Functional Capacity and Symptomatic Improvement

Symposium Agenda

  • Time - Session title and Objective - Speaker(s)
  • 20 mins - Improving Outcomes in Patients With Heart Failure – Optimization Through Personalization - Ileana L. Piña, Detroit, MI, USA
  • 20 mins - Optimising RAASi Therapy Through Long-Term Potassium Control - Javed Butler, Atlanta, GA, USA
  • 20 mins - Iron Therapy in Heart Failure – Impact on Exercise Capacity and Quality of Life - Peter van der Meer, Groningen, The Netherlands
  • 25 mins - Interactive Panel Discussion - Stefan Anker & Javed Butler

More from this programme

Part 1

Improving Outcomes in Patients With Heart Failure – Optimization Through Personalization

1 session
Improving Outcomes in Patients With Heart Failure – Optimization Through Personalization Watch now

Part 2

Optimising RAASi Therapy Through Long-Term Potassium Control

1 session
Optimising RAASi Therapy Through Long-Term Potassium Control Watch now

Part 3

Iron Therapy in Heart Failure – Impact on Exercise Capacity and Quality of Life

1 session
Iron Therapy in Heart Failure – Impact on Exercise Capacity and Quality of Life Watch now

Part 4

Panel Discussion

1 session
Panel Discussion Watch now

Faculty Biographies

Stefan Anker

Stefan Anker

Professor of Cardiology

Prof Stefan Anker is professor of (Tissue) Homeostasis in Cardiology & Metabolism at Charité Berlin, Germany, since June 2017. Prodigious researcher who has authored more than 1,000 articles. He has also won several prizes, including the 2018 Copernicus Prize of German DFG & Polish FNP. In October 2020, he was awarded a Doctor honoris causa of Medical University Wroclaw, Poland.

Prof Anker has been serving on the board of the Heart Failure Association (HFA) of the ESC since 2006 and was HFA President from 2012 to 2014. He currently chairs the HFA committee on regulatory affairs. He is founding Editor-in-Chief of the first open-access heart failure journal, ESC Heart Failure. Prof. Anker has served on several ESC Guideline task forces.

Prof Anker is the founding president of the International Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD) and founding Editor-in-Chief of the Journal of Cachexia, Sarcopenia and…

View full profile